Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:0A4J | London | Ordinary Share | ASTRAZENECA ADR REPRESENTING 0.5 ORD SHS |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 21:25:55 | O | 5 | 62.9588 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 02/1/2024 | 15:00 | UKREG | AstraZeneca PLC Total Voting Rights |
| 27/12/2023 | 07:00 | UKREG | AstraZeneca PLC AstraZeneca acquires Gracell |
| 22/12/2023 | 07:00 | UKREG | AstraZeneca PLC Wainua (eplontersen) granted first US FDA approval |
| 14/12/2023 | 15:00 | UKREG | AstraZeneca PLC Director/PDMR Shareholding |
| 12/12/2023 | 07:05 | UKREG | AstraZeneca PLC AstraZeneca to acquire Icosavax |
| 01/12/2023 | 15:05 | UKREG | AstraZeneca PLC Block listing Interim Review |
| 01/12/2023 | 15:00 | UKREG | AstraZeneca PLC Total Voting Rights |
| 01/12/2023 | 07:00 | UKREG | AstraZeneca PLC Discontinuation of two CRYSTALIZE evidence trials |
| 23/11/2023 | 15:00 | UKREG | AstraZeneca PLC Director/PDMR Shareholding |
Astrazeneca (0A4J) Share Charts1 Year Astrazeneca Chart |
|
1 Month Astrazeneca Chart |
Intraday Astrazeneca Chart |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 08:03:43 | 62.96 | 5 | 0.00 | O |
| 08:03:24 | 62.96 | 5 | 0.00 | O |
| 08:03:08 | 63.03 | 1 | 0.00 | O |
| 08:02:58 | 62.94 | 1 | 0.00 | O |
| 08:02:48 | 63.03 | 1 | 0.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
